How will CRISPR gene editing change healthcare?
For years, one medical technology has captivated the scientific community: CRISPR. In 2012, Emmanuelle Charpentier, a microbiologist, geneticist and biochemist,...
Year: 2024
Tecovirimat (TPOXX) IND Information
Oral Tecovirimat Access through the NIH STOMP Trial Oral tecovirimat for treatment of mpox is primarily available through enrollment in...
Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities
Cowan AJ, Green DJ, Kwok M, Lee S, Coffey DG, Holmberg LA, et al. Diagnosis and management of multiple myeloma:...
A Feasibility Test of a Brief Mobile Virtual Reality Meditation for Frontline Healthcare Workers in a Hospital Setting
IntroductionCOVID-19, first identified in December of 2019, became a worldwide pandemic causing major disruption and loss of life. The disease...
UK medicines regulator approves world-first gene-editing treatment for blood disorders
UK medicines regulator approves world-first gene-editing treatment for blood disorders The UK has...
Peterson Report Finds Value in Virtual Musculoskeletal Solutions
In March 2024, the Peterson Health Technology Institute (PHTI), which has begun conducting independent evaluations of healthcare technologies, released an...
Virtual physical therapy can improve outcomes, spending
Photo: Marko Geber/Getty Images For people with a range of musculoskeletal (MSK) conditions, many virtual physical therapy options can deliver...
World’s first CRISPR-based gene therapy approved for sickle cell anaemia
Casgevy has been approved for treating sickle cell disease and transfusion-dependent beta thalassemia patients aged 12 and older in the...
Best Gene-Editing Stocks to Buy in 2024
Image source: Getty Images. In 2020, American biochemist Jennifer Doudna and French microbiologist Emmanuelle Charpentier were awarded the Nobel Prize...
